Skip to content
pharmaceutical hero image
pharmaceutical hero image

Pharmaceuticals

We act for many of the world’s largest pharmaceutical companies, giving us broad and deep insights into the key trends and risks facing companies operating in the sector.

We advise on a wide range of complex cases, working with both national and international clients on high-profile and strategic matters. We have gathered significant and relevant experience of acting for leading companies in the life sciences sector on regulatory issues and we have built a track record of running a number of multi-jurisdictional matters. We also have a strong offering advising pharmaceuticals on transactions including M&A, collaborations and fundraising. Our clients include Novartis, Pfizer, Bayer, Merck, GSK, and Johnson & Johnson among many others.

News and insights

Lab worker using syringe

Blog Post: 01 February 2023

Clinical Trial Regulation: Balancing Transparency Requirements and Protection of CCI – new Q&A published

The Clinical Trial Regulation (EU) No 536/2014 (CTR) became fully applicable yesterday (31 January), following the end of the transition period. Therefore, the use of the Clinical Trial Information…

Read more
Heap of medical pills in white, blue and other colors. Pills in plastic package. Concept of healthcare and medicine.

Blog Post: 04 January 2023

Why AI drug discovery deals are different from traditional pharma collaborations

Pharma companies have been working with artificial intelligence (AI) for a decade or more. As the cost and time of bringing a new drug to market continues to rise, pharma companies are increasingly…

Read more
Senior Male Research Scientist is Using a Tablet Computer in a Modern High-Tech Laboratory. Genetics and Pharmaceutical Studies and Researches.

Blog Post: 21 December 2022

New date for the proposal of a revised EU pharmaceutical legislation

On 25 November 2020, the European Commission announced in its Communication for a Pharmaceutical Strategy for Europe a thorough review of the EU pharmaceutical legislation, which was originally…

Read more
Pharmaceutical Optical Ampoule / Vial Inspection Machine. 3d illustration

Blog Post: 16 December 2022

European Commission investigation into Teva’s potential abuse of dominance – misuse of patent procedures and disparagement

On 10 October 2022, the European Commission (EC) sent a Statement of Objections to Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals Europe BV (Teva). The EC has provisionally found that…

Read more

Download our sector brochure

Life sciences A&O red molecules

Our Life Sciences and Healthcare sector focus 2022

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.